VIP: the complete guide.

The short version.

If you read nothing else, read this. The whole guide in a handful of bullets.

Quick reference.

What is VIP?

VIP is a short peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. It is a synthetic copy of Vasoactive Intestinal Peptide, a 28-amino-acid molecule your body already makes and uses as a signal.

Naturally, VIP shows up in the gut, lungs, nerves, and immune system, where it acts as one of the body's own anti-inflammatory signals. It tells overactive immune cells to settle down and helps relax blood vessels. Researchers noticed that some chronically inflamed patients have very low VIP, which is what led to giving it back as a therapy.

The version sold by vendors arrives as a freeze-dried white powder in a small sealed vial, and people mix it into a nasal spray. It is not a steroid, not a hormone in the muscle-building sense, and not a stimulant. People reach for it for one theme above all: calming the kind of stubborn, body-wide inflammation that does not respond to the usual measures.

Worth saying plainly: VIP is not an approved medicine for general use. It is sold strictly for research use only, and the strongest human evidence comes from a small group of CIRS studies by a single research team, plus separate hospital research on a close relative called aviptadil. We get into what that means further down.

How it works in the body.

You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.

The core idea is that VIP works with the body's own anti-inflammatory machinery. Rather than acting in one spot, it is a signal that travels widely and tells the immune system to cool down. It does this through a few overlapping mechanisms that show up repeatedly in the research.

• VPAC receptor signaling. VIP binds two receptors, VPAC1 and VPAC2, on immune cells and tissue. This raises a messenger called cAMP inside the cell, which is the switch that drives most of its calming effects.
• Lower inflammatory cytokines. Through those receptors it suppresses pro-inflammatory signals like TNF-α, IL-6, and IL-12, and nudges immune cells from an inflammatory state toward a resolving one. This is the heart of why people run it.
• Vasodilation and tissue support. VIP also relaxes blood vessels and smooth muscle, which supports the lungs and gut and is why a warm flush can follow a dose. It is studied for the brain too, which is part of why the nasal route is used.

How to take it: routes of administration.

VIP is really a nasal-spray peptide. Because it is broken down in the bloodstream within minutes, it is dosed several times a day, and the published protocols use the intranasal route. A subcutaneous version exists as a second option. Here is the honest comparison.

So which should a beginner pick? For almost everyone, intranasal is the answer: it is needle-free, it matches the published protocols, and it spreads the short-acting peptide across the day. The subcutaneous version is a reasonable option if you would rather take two shots than four sprays, but it is not the standard.

Dosing by goal.

There is no single official dose for VIP, because it is not an approved medicine for general use. What follows is the range people commonly run, drawn mostly from the published CIRS work. The defining feature of VIP dosing is frequent small doses, because it does not last long in the body.

Standard intranasal

The pattern from the published CIRS research is one spray of about 50 mcg, four times a day, alternating nostrils. Some protocols step up to two sprays four times daily in a second month. The frequency matters because VIP clears the bloodstream in roughly two minutes.

Subcutaneous option

For people who prefer a shot, a common pattern is about 50 mcg subcutaneously in the morning and 50 mcg in the evening, sometimes cycled eight weeks on and eight weeks off. It delivers the peptide systemically without four daily sprays.

Where it fits in a protocol

In CIRS work VIP is deliberately the last step, added only after other markers and the environment are addressed. Starting it too early, before those root causes are handled, is widely discouraged in the protocols people follow.

Cycling and timing.

A cycle just means a defined run of time on the peptide, followed by a break. With VIP the common approach is to run it as the final step of a longer protocol, hold it for a stretch while markers improve, then taper rather than stopping abruptly or running it forever.

Why not just run it forever? Mostly because the long-term human safety data does not exist outside the small CIRS cohorts. The cautious and widely followed approach is to use it within a structured protocol, under a provider, then step down.

• Hold the schedule across the day, four sprays at roughly even spacing, so levels stay topped up.
• Step down, do not just quit cold if you are tapering off, reducing frequency gradually.
• Take a real break after a run before considering another. If symptoms return, that is a conversation for a licensed provider, not a forum.

Stacking VIP.

VIP is rarely the only thing in a protocol. It is usually layered on top of repair and anti-inflammatory peptides once the groundwork is done.

See full recipes, dosing, and how people run them on the stacks page.

Side effects and safety.

In the reports we see, VIP is generally described as well tolerated, with side effects that follow from its main action, relaxing blood vessels. The ones people mention most often are:

• Facial flushing or warmth shortly after a dose, from vasodilation. Usually mild and brief.
• Lightheadedness or a brief drop in blood pressure, which is why people start low and pay attention to how they feel.
• Loose stools or diarrhea, since VIP also affects the gut.
• Mild nasal irritation from the spray itself, which is why people alternate nostrils.

Who should be cautious.

Some people have clear reasons to be extra careful, or to avoid VIP entirely until they have spoken with a licensed provider.

• Low blood pressure or fainting spells. VIP dilates blood vessels and can lower blood pressure, so this group should be especially cautious.
• Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
• A history of cancer, or active cancer. VIP is a growth and signaling molecule and some tumors carry its receptors, so caution is widely advised. This is a conversation for an oncologist, not a forum.
• Anyone on blood-pressure or other medications. If you take prescription drugs or manage a chronic condition, talk to your provider first.

And the universal one: whoever you are, talk to a licensed healthcare provider before starting VIP. This guide is educational, not a substitute for personalized medical advice.

Where to buy it safely.

This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. Our honest take: do not shop on price alone, shop on price plus independent lab data.

• Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
• Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
• Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
• Be skeptical of suspiciously cheap listings with no testing behind them.

That is exactly the comparison we put together. On our VIP product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.

Questions, answered straight.